Gene: TRAPPC9
Official Full Name: trafficking protein particle complex subunit 9provided by HGNC
Gene Summary: This gene encodes a protein that likely plays a role in NF-kappa-B signaling. Mutations in this gene have been associated with autosomal-recessive cognitive disability. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25397 | TRAPPC9 Knockout cell line (HeLa) | Human | TRAPPC9 | 1:3~1:6 | Negative | Online Inquiry |
KO25398 | TRAPPC9 Knockout cell line (HCT 116) | Human | TRAPPC9 | 1:2~1:4 | Negative | Online Inquiry |
KO25399 | TRAPPC9 Knockout cell line (HEK293) | Human | TRAPPC9 | 1:3~1:6 | Negative | Online Inquiry |
KO25400 | TRAPPC9 Knockout cell line (A549) | Human | TRAPPC9 | 1:3~1:4 | Negative | Online Inquiry |
TRAPPC9 Gene Knockout Cell Lines are a specialized biological product designed to facilitate advanced research into the TRAPPC9 gene, known for its role in vesicle trafficking and intracellular transport processes. These cell lines are genetically engineered to lack functional TRAPPC9 expression, allowing researchers to investigate the gene's biological functions and implications in various cellular contexts, including neurodevelopment and cognitive function.
The primary mechanism by which TRAPPC9 Gene Knockout Cell Lines operate involves the disruption of the normal vesicle transport pathways within cells. By knocking out TRAPPC9, these cell lines enable the study of altered signaling pathways and protein interactions that are mediated by this critical gene. This model is particularly crucial for understanding its involvement in neurological disorders and other pathologies linked to intracellular transport dysfunctions.
In scientific research settings, TRAPPC9 Gene Knockout Cell Lines are invaluable for dissecting the molecular mechanisms underlying TRAPPC9-related diseases. They provide a robust platform for pharmacological studies, gene therapy research, and the development of therapeutic strategies aimed at correcting the deficits caused by TRAPPC9 disruption. Their application extends to both in vitro studies and potential in vivo models, aiding in translational research efforts to improve patient outcomes.
The advantages of using TRAPPC9 Gene Knockout Cell Lines over traditional methods include significant time savings and increased specificity in genetic analysis. Compared to other models that may not fully replicate the functional absence of TRAPPC9, these knockout lines offer clearer insights due to their defined genetic background, enhancing the reproducibility of experiments and allowing for precise conclusions.
For researchers and clinicians dedicated to understanding the nuances of gene function and its relation to disease, TRAPPC9 Gene Knockout Cell Lines present an indispensable tool. By providing a clear pathway to explore therapeutic avenues and understand complex biological processes, these cell lines represent a remarkable advancement in genetic research. Our company is dedicated to supporting the scientific community with high-quality, rigorously validated biological products to drive innovation and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.